Aller au contenu principal
Profil bibliographique

Juliet Meir

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

16Publications signalées
101Citations signalées
2Affiliations récentes

Les institutions déclarées

Les domaines associés

Lymphoma Diagnosis and TreatmentLung Cancer Treatments and MutationsLung Cancer Research StudiesDiabetes Treatment and ManagementBariatric Surgery and Outcomes

Les publications récentes

2026 conference-abstract OpenAlex

Association of carbon tetrachloride with lung cancer incidence and mortality, including effects in low-smoking regions.

Ashish Samaddar, Alexandra Feathers, Srinivas Govindan, Shuyi Chen et autres

8076 Background: Although cigarette smoking is the main risk factor for lung cancer, 10–20 percent of cases occur in non-smokers, with women disproportionately affected. This pattern suggests that community-level environmental exposures may contribute to lung cancer risk beyond smoking. Methods: In this …

us (code pays fourni par la source)

0 citations Journal of Clinical Oncology
2026 article OpenAlex

Understanding perceptions and barriers to clinical trial participation in multicultural communities.

Ethan Paul Royka, Chase A. Shipp, Nhi D. Nguyen, Phyu Thin Naing et autres

e13502 Background: Racial, ethnic, and linguistic minorities remain underrepresented in clinical trials. While structural barriers to enrollment are well documented, patient perceptions and cultural factors influencing participation remain understudied. This study aims to assess patient perceptions and barriers to trial participation and …

us (code pays fourni par la source)

0 citations Journal of Clinical Oncology
2026 conference-abstract OpenAlex

De novo vs recurrent metastatic presentation and outcomes with first-line EGFR TKI in EGFR -mutant NSCLC.

Wint Yan Aung, Divya Chukkalore, NEHEMIAS GUEVARA, Nina Cheranda et autres

e20766 Background: Approximately 20% of EGFR-mutant metastatic non-small cell lung cancer (NSCLC) presents as recurrent disease in real-world practice. Whether metastatic presentation (de novo vs recurrent) influences treatment durability and disease control on first-line (1L) EGFR tyrosine kinase inhibitors (TKIs) is unknown. …

us, ph (code pays fourni par la source)

0 citations Journal of Clinical Oncology
2026 conference-abstract OpenAlex

Age-vulnerability interaction and real-world treatment outcomes in EGFR -mutant non–small cell lung cancer.

Juliet Meir, Divya Chukkalore, Wint Yan Aung, NEHEMIAS GUEVARA et autres

e20685 Background: Older adults with EGFR-mutant metastatic non-small cell lung cancer (NSCLC) are underrepresented in clinical trials, and treatment decisions often rely on chronological age rather than biologic reserve. Whether vulnerability modifies the relationship between age and real-world treatment outcomes remains unknown. …

us, ph (code pays fourni par la source)

0 citations Journal of Clinical Oncology
Accès ouvert 2026 article OpenAlex

Real-world outcomes of polatuzumab, rituximab, and lenalidomide in frail pts with diffuse large B-cell lymphoma.

Monica Wallin, Juliet Meir, Teshmanie Rampersaud, Sally Ko et autres

e19055 Background: Patients (pts) with diffuse large B-cell lymphoma (DLBCL) who are elderly, frail, or have cardiac comorbidities are frequently ineligible for anthracycline-based chemotherapy and are underrepresented in clinical trials. Chemotherapy-sparing regimens incorporating antibody–drug conjugates and immunomodulatory agents may provide an alternative …

us (code pays fourni par la source)

0 citations Journal of Clinical Oncology
2025 conference-abstract OpenAlex

Integrating next-generation sequencing (NGS) as standard of care in the management of early-stage non-small cell lung cancer (NSCLC): A quality imperative.

Juliet Meir, Adrian Choppa, Shuyi Chen, Nagashree Seetharamu

498 Background: NGS remains underutilized in early-stage NSCLC which results in missed opportunities to personalize therapy. Timely molecular profiling is critical to ensure actionable results are available prior to multidisciplinary planning. Institutional studies suggest that preoperative NGS on biopsy specimens does not …

us (code pays fourni par la source)

0 citations JCO Oncology Practice
2025 conference-abstract OpenAlex

Abstract 3623: Racial disparities in front-line use of novel agents and stem cell transplants among patients with multiple myeloma

Phyu Thin Naing, Kelvin Zheng, Divya Chukkalore, Richa Thakur et autres

Abstract Background: Racial disparities in incidence, mortality, and access to care persist in multiple myeloma (MM). Black/African Americans remain underrepresented in pivotal clinical trials, such as MAIA and PERSEUS, that led to the approval of novel agents like daratumumab (Dara). Dara received …

us (code pays fourni par la source)

0 citations Cancer Research
Accès ouvert 2024 article OpenAlex

Acute coronary syndrome due to coronary vasospasm: a case report

Andy Wang, Juliet Meir, Aaqib H. Malik, Tzvi Fishkin et autres

Coronary vasospasm can lead to decreased cardiac perfusion and result in acute coronary syndrome. Here is a case of a 49-year-old man presented to the emergency department with epigastric pain and nausea with normal initial electrocardiogram. However, 6 h later, the patient …

us (code pays fourni par la source)

0 citations Future Cardiology
2024 article OpenAlex

Cardiovascular Disease and Dementia: Exploring Intersections, Risks, and Therapeutic Challenges

Lillian Huang, Juliet Meir, William H. Frishman, Wilbert S. Aronow

This review examines the complex bidirectional relationship between cardiovascular disease and various dementia subtypes, including Alzheimer's disease, vascular dementia, Lewy body dementia, and frontotemporal dementia. Traditional cardiovascular risk factors such as hypertension, coronary artery disease, arrhythmia, and diabetes mellitus are strongly linked …

us (code pays fourni par la source)

9 citations Cardiology in Review
2023 article OpenAlex

The vascular complications of diabetes: a review of their management, pathogenesis, and prevention

Juliet Meir, Lillian Huang, Sumaita Mahmood, Harris Z. Whiteson et autres

INTRODUCTION: This review highlights the pathogenesis of both microvascular and macrovascular complications of diabetes and how these mechanisms influence both the management and preventative strategies of these complications. The cumulative data shown in this review suggest hyperglycemic and blood pressure control remain …

us (code pays fourni par la source)

37 citations Expert Review of Endocrinology & Metabolism
Accès ouvert 2023 article OpenAlex

Mediastinal Mass as an Initial Presentation of Acute Myeloid Leukemia in a Young Man

Yagya Ahlawat, Juliet Meir, C. Benjamin, Amir Steinberg

A 29-year-old male, hemodynamically stable, presented with chest pain radiating to the interscapular region, with no fever, cough, dyspnea, or other constitutional symptoms. He had right cervical lymphadenopathy on physical examination. Investigations revealed a 3.1 cm anterior mediastinal nodular mass, peripheral immature …

us (code pays fourni par la source)

0 citations Cureus
2023 article OpenAlex

Safety and cardiometabolic efficacy of novel antidiabetic drugs

Liana Michaud, Matthew Seplowe, Juliet Meir, Wilbert S. Aronow

INTRODUCTION: There are three major drug classes discussed in this review: dipeptidyl dipeptidase-4 (DPP4) inhibitors, glucagon-like peptide-1 receptor agonists (GLP-1 RAS), and sodium-glucose cotransporter-2 (SGLT2) inhibitors. A literature review of the landmark cardiovascular outcome trials from 2008 to 2021 was conducted. AREAS …

us (code pays fourni par la source)

2 citations Expert Opinion on Drug Safety

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.